Mass spectrometric identification of novel posttranslational modification sites in Huntingtin

Proteomics

Volumn 12, Issue 12, 2012, Pages 2060-2064

  Dong, Gaofeng ^a   Callegari, Eduardo ^a   Gloeckner, Christian J ^b,c   Ueffing, Marius ^b,c   Wang, Hongmin ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Biomedicine; Mass spectrometry; Phosphorylation; Posttranslational modification; Tandem affinity purification; Ubiquitination

Indexed keywords

HUNTINGTIN;

ARTICLE; CYTOTOXICITY; EMBRYO; HUMAN; HUMAN CELL; HUNTINGTON CHOREA; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING; WILD TYPE;

AMINO ACID SEQUENCE; CHROMATOGRAPHY, AFFINITY; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; TANDEM MASS SPECTROMETRY; UBIQUITINATION;

EID: 84862978755     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201100380     Document Type: Article

References (19)

1. The Huntington's Disease Collaborative Research Group, A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72, 971-983.
2. Lombardi, M. S., Jaspers, L., Spronkmans, C., Gellera, C. et al., A majority of Huntington's disease patients may be treatable by individualized allele-specific RNA interference. Exp. Neurol. 2009, 217, 312-319.
3. Orr, H. T., Zoghbi, H. Y., Trinucleotide repeat disorders. Annu. Rev. Neurosci. 2007, 30, 575-621.
4. Steffan, J. S., Agrawal, N., Pallos, J., Rockabrand, E. et al., SUMO modification of Huntingtin and Huntington's disease pathology. Science 2004, 304, 100-104.
5. Gu, X., Greiner, E. R., Mishra, R., Kodali, R. et al., Serines 13 and 16 are critical determinants of full-length human mutant huntingtin induced disease pathogenesis in HD mice. Neuron 2009, 64, 828-840.
6. Aiken, C. T., Steffan, J. S., Guerrero, C. M., Khashwji, H. et al., Phosphorylation of threonine 3: implications for Huntingtin aggregation and neurotoxicity. J. Biol. Chem. 2009, 284, 29427-29436.
7. Thompson, L. M., Aiken, C. T., Kaltenbach, L. S., Agrawal, N. et al., IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J. Cell. Biol. 2009, 187, 1083-1099.
8. Zala, D., Colin, E., Rangone, H., Liot, G. et al., Phosphorylation of mutant huntingtin at S421 restores anterograde and retrograde transport in neurons. Hum. Mol. Gen. 2008, 17, 3837-3846.
9. Yanai, A., Huang, K., Kang, R., Singaraja, R. R. et al., Palmitoylation of huntingtin by HIP14 is essential for its trafficking and function. Nat. Neurosci. 2006, 9, 824-831.
10. Jeong, H., Then, F., Melia, T. J., Jr., Mazzulli, J. R. et al., Acetylation targets mutant huntingtin to autophagosomes for degradation. Cell 2009, 137, 60-72.
11. Gloeckner, C. J., Boldt, K., Schumacher, A., Ueffing, M., Tandem affinity purification of protein complexes from mammalian cells by the Strep/FLAG (SF)-TAP tag. Methods Mol. Biol. 2009, 564, 359-372.
12. Rigaut, G., Shevchenko, A., Rutz, B., Wilm, M. et al., A generic protein purification method for protein complex characterization and proteome exploration. Nat. Biotechnol. 1999, 17, 1030-1032.
13. Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B. et al., Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996, 87, 493-506.
14. Ratovitski, T., Gucek, M., Jiang, H., Chighladze, E. et al., Mutant huntingtin N-terminal fragments of specific size mediate aggregation and toxicity in neuronal cells. J. Biol. Chem. 2009, 284, 10855-10867.
15. Dong, G., Callegari, E. A., Gloeckner, C. J., Ueffing, M. et al., Prothymosin-alpha interacts with mutant Huntingtin and suppresses its cytotoxicity in cell culture. J. Biol. Chem. 2012, 287, 1279-1289.
16. Schilling, B., Gafni, J., Torcassi, C., Cong, X. et al., Huntingtin phosphorylation sites mapped by mass spectrometry. Modulation of cleavage and toxicity. J. Biol. Chem. 2006, 281, 23686-23697.
17. Luo, S., Vacher, C., Davies, J. E., Rubinsztein, D. C., Cdk5 phosphorylation of huntingtin reduces its cleavage by caspases: implications for mutant Huntingtin toxicity. J. Cell. Biol. 2005, 169, 647-656.
18. Kimura, Y., Yashiroda, H., Kudo, T., Koitabashi, S. et al., An inhibitor of a deubiquitinating enzyme regulates ubiquitin homeostasis. Cell 2009, 137, 549-559.
19. Zuccato, C., Valenza, M., Cattaneo, E., Molecular mechanisms and potential therapeutical targets in Huntington's disease. Physiol. Rev. 2010, 90, 905-981.